Balyasny Asset Management
LXRX icon

Balyasny Asset Management’s Lexicon Pharmaceuticals LXRX Stock Holding History

Balyasny Asset Management’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-34,433
Closed -$82.6K – 2923
2024
Q1 		$82.6K Buy
+34,433
New +$74K ﹤0.01% 2505
2023
Q1 		– Sell
-38,377
Closed -$73.3K – 2967
2022
Q4 		$73.3K Buy
+38,377
New +$81.7K ﹤0.01% 2290
2022
Q3 		– Sell
-16,363
Closed -$30K – 3131
2022
Q2 		$30K Buy
+16,363
New +$31.2K ﹤0.01% 2425
2018
Q4 		– Sell
-103,741
Closed -$1.11M – 1611
2018
Q3 		$1.11M Buy
+103,741
New +$1.19M 0.01% 1153
2017
Q2 		– Sell
-731,985
Closed -$10.5M – 1635
2017
Q1 		$10.5M Buy
731,985
+13,480
+2% +$200K 0.06% 475
2016
Q4 		$9.94M Buy
718,505
+166,605
+30% +$2.67M 0.06% 479
2016
Q3 		$9.97M Buy
551,900
+370,786
+205% +$5.97M 0.06% 385
2016
Q2 		$2.6M Buy
181,114
+49,070
+37% +$666K 0.02% 639
2016
Q1 		$1.58M Buy
+132,044
New +$1.38M 0.01% 727
2015
Q4 		– Sell
-600,951
Closed -$6.45M – 1375
2015
Q3 		$6.45M Buy
+600,951
New +$6.56M 0.06% 456

Other funds holding LXRX

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return